CASE STUDIES
Working with Start-ups/SMEs (Acuitive)
CITREGEN™ A novel bioactive platform technology for musculoskeletal applications. A journey from validation through to FDA clearance. In collaboration with CÚRAM, Acuitive Technologies, Inc. has validated the scientific potential of their groundbreaking bioactive CITREGEN™ platform technology to accelerate tissue healing and address challenges associated with currently available biodegradable devices across various musculoskeletal applications.
-
Led by CÚRAM FI
Manus Biggs

